CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 148 enrolled
Drug / intervention
Optitherm® device activated +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01667848
NCT01667848N/ACompleted
CompareCT.gov

Warmed, Humidified Carbon Dioxide Insufflation vs Standard Carbon Dioxide in Laparoscopic Cholecystectomy: a Double-blinded Randomized Controlled Trial

Kepler University Hospital·interventional·Posted Aug 17, 2012·Updated Oct 5, 2023

In Brief

A clinical study evaluating Optitherm® device activated and Optitherm® device inactivated for Cholecystolithiasis. Completed, enrolled 148 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the effect of warmed, humidified carbon dioxide Insufflation vs standard carbon dioxide in laparoscopic cholecystectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCholecystolithiasis
CountriesAustria
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 17, 2012
Enrollment StartJul 1, 2011
Primary CompletionJul 1, 2013
Study CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 13.9 years ago

Interventions

Optitherm® device activateddevice

The use of Optitherm® device, which was attached to the insufflation equipment in all of the patients but was only activated by the single scrub nurse in those patients randomized to group B.

Optitherm® device inactivateddevice

The use of Optitherm® device, which was attached to the insufflation equipment in all of the patients but was inactivated in group A.